Evidence map›Paper›PMID 42109786›Full record

ArticleEFSA journal. European Food Safety Authority2015

Scientific support for preparing an EU position in the 47th Session of the Codex Committee on Pesticide Residues (CCPR).

European Food Safety Authority

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Use of conversion factors for the setting of MRLs of prothioconazole.EFSA journal. European Food Safety Authority · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Setting of import tolerances for mandipropamid in papayas.EFSA journal. European Food Safety Authority · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Modification of the existing MRLs for propamocarb in various crops.EFSA journal. European Food Safety Authority · 2015
    Article
  13. Setting of an import tolerance for chlorothalonil in cranberries.EFSA journal. European Food Safety Authority · 2015
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

European Food Safety Authority

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to provide support for the preparation of the EU position for 47th session of the Codex Committee on Pesticide Residues (CCPR). In 2014 JMPR evaluated 15 active substances regarding the setting of toxicological reference values to be used in consumer risk assessment (aminocyclopyrachlor, benzovindiflupyr, cyflumetofen, dichlobenil, emamectin benzoate, fenamidone, fluensulfone, flufenoxuron, imazamox, mesotrione, metrafenone, myclobutanil, pymetrozine and triforine) and 32 active substance regarding the setting of Maximum Residue Limits (MRLs) (aminocyclopyrachlor, benzovindiflupyr, buprofezin, chlorantraniliprole, chlothianidin, cyflumetofen, dichlobenil, dimethomorph, dithiocarbamates (mancozeb), emamectin benzoate, fenamidone, fenpropathrin, fluensulfone, flufenoxuron, fluopyram, glufosinate, imazamox, mesotrione, metrafenone, myclobutanil, phosmet, propamocarb, propiconazole, prothioconazole, pymetrozine, pyraclostrobin, sedaxane, spirodiclofen, sulfoxaflor, thiamethoxam, triadimenol and triforine). The relevant findings that should serve as the basis for deriving the EU position for the CCPR meeting are summarised in this report.

Indexed as

CCPR meeting 2015Consumer risk assessmentMRL settingresidue definitionstoxicological evaluation

Identifiers

PMID42109786
PMCPMC13151657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.